---
title: "Konrad H. Stopsack, MD MPH"
image: "stopsack.jpg"
titles:
  - description: "Research Scientist"
  - description: "Department of Epidemiology"
  - description: "Harvard T.H. Chan School of Public Health"
links:
  - label: '`r gs <- icons::academicons("google-scholar"); 
            gs$attribs$viewBox <- "0 0 448 512"; 
            gs` Google Scholar'
    url: "https://scholar.google.com/citations?user=7jN6YU0AAAAJ&hl=en&num=20&oi=ao"
  - label: '`r or <- icons::academicons("orcid"); 
            or$attribs$viewBox <- "0 0 512 512"; 
            or` ORCID'
    url: "https://orcid.org/0000-0002-0722-1311"
  - label: '`r icons::fontawesome("github")` Github'
    url: "https://github.com/stopsack"
links-row2:
  - label: '`r icons::fontawesome("envelope")` stopsack@post.harvard.edu'
    url: "mailto:stopsack@post.harvard.edu"
output:
  postcards::trestles
---

<p style="margin-top:2rem;"> </p>

I am a <span class="highlight">molecular and clinical epidemiologist with a focus on cancer epidemiology</span> and a background as a board-certified internal medicine physician. My main research interest is how potentially modifiable exposures cause solid tumors through genomic heterogeneity and influence cancer progression. I am passionate about combining well-defined observational studies and state-of-the-art genomics in order to guide cancer prevention and treatment. My methodologic and teaching interests include application and further development of epidemiologic methods for high-dimensional biomarker studies and clinical studies.

With a <span class="highlight">highly interdisciplinary research program</span>, I bring together and lead teams across epidemiology, genomics, pathology, bioinformatics, clinical medicine, and preclinical research. My research has been funded by a Prostate Cancer Foundation Young Investigator Award, a Department of Defense Early-Investigator Research Award, and several other third-party grants.

## Education

**Memorial Sloan Kettering Cancer Center** | New York, NY<br />
Postdoctoral Training in Cancer Epidemiology | 2021

**Mayo Clinic** | Rochester, MN<br />
Residency/Board Certification in Internal Medicine | 2017

**Harvard School of Public Health** (now Harvard T.H. Chan School of Public Health) | Boston, MA<br />
M.P.H. in Epidemiology/Biostatistics | 2014

**University of Freiburg** | Freiburg, Germany<br />
M.D. | 2013; Dr. med. | 2014

## Selected Publications

1. **Stopsack KH**, Nandakumar S, Arora K, Nguyen B, Vasselman SE, Nweji B, McBride SM, Morris MJ, Rathkopf DE, Slovin SF, Danila DC, Autio KA, Scher HI, Mucci LA, Solit DB, Gönen M, Chen Y, Berger MF, Schultz N, Abida W,\* Kantoff PW\* (\* equal contribution). Differences in prostate cancer genomes by self-reported race: Contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors. *Clin Cancer Res*. 2021. [Journal article](https://doi.org/10.1158/1078-0432.CCR-21-2577) | [Dataset on cBioPortal](http://www.cbioportal.org/study/summary?id=prad_msk_stopsack_2021)

2. Drago JZ, Gönen M, Thanarajasingam G, Sacks CA, Morris MJ, Kantoff PW, **Stopsack KH.** Inferences about drug safety in phase 3 trials in oncology: Examples from advanced prostate cancer. *JNCI J Natl Cancer Inst*. 2021;113(5):553-561. [Journal article with free full text](https://academic.oup.com/jnci/advance-article/doi/10.1093/jnci/djaa134/5898636?guestAccessKey=95f5041a-ead1-4ef4-b05a-3f88e672b4db) \| [Accompanying editorial](https://academic.oup.com/jnci/advance-article/doi/10.1093/jnci/djaa135/5898637)

3. **Stopsack KH**, Huang Y, Tyekucheva S, Gerke TA, Bango C, Elfandy H, Bowden M, Penney KL, Roberts TM, Parmigiani G, Kantoff PW, Mucci LA, Loda M. Multiplex immunofluorescence in formalin-fixed paraffin-embedded tumor tissue to identify single cell-level PI3K pathway activation. *Clin Cancer Res*. 2020;26(22):5903-5913. [Journal article](https://doi.org/10.1158/1078-0432.CCR-20-2000) \| [Cover image](https://clincancerres.aacrjournals.org/content/26/22.cover-expansion) \| [Free fulltext](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669556)
	
4. **Stopsack KH**, Nandakumar S, Wibmer AG, Haywood S, Weg ES, Barnett ES, Kim CJ, Carbone EA, Vasselman SE, Nguyen B, Hullings MA, Scher HI, Morris MJ, Solit DB, Schultz N, Kantoff PW\*, Abida W\* (\* equal contribution). Oncogenic genomic alterations, clinical phenotypes, and outcomes in metastatic castration-sensitive prostate cancer. *Clin Cancer Res*. 2020;26(13):3230-3238. [Journal article](https://doi.org/10.1158/1078-0432.CCR-20-0168) \| [Free fulltext](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334067) \| [Results and supplement with hyperlinks](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334067/bin/NIHMS1580358-supplement-1.html) \| [Dataset on cBioPortal](https://www.cbioportal.org/study/summary?id=prad_mcspc_mskcc_2020)
	
5. **Stopsack KH**, Whittaker CA, Gerke TA, Loda M, Kantoff PW, Mucci LA, Amon A. Aneuploidy drives lethal progression in prostate cancer. *Proc Natl Acad Sci U S A*. 2019;116(23):11390-11395. [Journal article with free full text](https://doi.org/10.1073/pnas.1902645116)

[Complete List of Publications](https://scholar.google.com/citations?user=7jN6YU0AAAAJ&hl=en&num=20&oi=ao)

## Methods and Software

1. **Stopsack KH**, Tyekucheva S, Wang M, Gerke TA, Vaselkiv JB, Penney KL, Kantoff PW, Finn SP, Fiorentino M, Loda M, Lotan TL, Parmigiani G\*, Mucci LA\* (* equal contribution). Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays. [bioRxiv preprint](https://www.biorxiv.org/content/10.1101/2021.06.29.450369v2) (June 30, 2021) | [*batchtma* R package: download, documentation, and vignettes](https://stopsack.github.io/batchtma/).

2. *risks* R package: Estimating risk ratio and risk differences using regression. [risks R package: download, documentation, and vignettes](https://stopsack.github.io/risks/)

3. Keegan NM, Vasselman SE, Barnett ES, Nweji B, Carbone EA, Blum A, Morris MJ, Rathkopf DE, Slovin SF, Danila DC, Autio KA, Kantoff PW, Abida W,\* **Stopsack KH**\* (\* equal contribution). Clinical Annotations for Prostate Cancer Research: Defining Data Elements, Creating a Reproducible Analytical Pipeline, and Assessing Data Quality. [medRxiv preprint](https://doi.org/10.1101/2021.09.20.21263842) (Sep 20, 2021) | [*prostateredcap* R package: download, documentation, and vignettes](https://stopsack.github.io/prostateredcap).


```{css echo=FALSE}
.highlight{
  color: #D16103; 
}
.highlight-secondary {
  color: #4E84C4;
}
.section.level2 h2 {
  color: #4E84C4;
}
```